Indications |
Intramuscular Active immunisation against hepatitis A Adult: Single dose of 0.5 ml or 1 ml depending on the product and the age of the patient. Booster dose is usually given 6-12 mth after the initial dose. To be given via SC admin in haemophiliacs. Child: Same as adult. |
Contraindications |
Hypersensitivity. Vaccines prepared in egg cultures are contraindicated in patients with hypersensitivity reactions to egg. Severe immunodeficiency. Malignant disease being treated with chemotherapy or radiotherapy and for at least 6 mth after stopping treatment. Patients with compromised immune system such as those on high-dose systemic corticosteroids, immunosuppressants or HIV positive. |
Warnings / Precautions |
Alcohol or disinfectant used for cleaning the skin prior to inj should be allowed to evaporate completely before vaccination to prevent vaccine inactivation. |
Adverse Reactions |
Transient soreness, erythema, induration at inj site. Fever, malaise, Potentially Fatal: Anaphylaxis. |
Drug Interactions |
Reduced response to vaccination when used concurrently with immunosuppressants such as corticosteroids or antineoplastics. See Below for More vaccine, hepatitis a Drug Interactions |
Mechanism of Actions |
Hepatitis A antigen is prepared from formaldehyde-inactivated hepatitis A virus grown in human diploid cells. It is used for active immunisation against hepatitis A infection. |
Available As |
|
Hepatitis A Vaccine
Post Review about Hepatitis A Vaccine Click here to cancel reply.
Hepatitis A Vaccine Containing Brands
Hepatitis A Vaccine is used in following diseases
Drug - Drug Interactions of Hepatitis A Vaccine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.